131 related articles for article (PubMed ID: 6673027)
1. [Can normovolemic hemodilution really modify blood flow in the limbs?].
Guerrini M; Pieragalli D; Acciavatti A; Cappelli R; Pecchi S; Forconi S; Di Perri T
Ric Clin Lab; 1983; 13 Suppl 3():439-44. PubMed ID: 6673027
[TBL] [Abstract][Full Text] [Related]
2. Normovolemic hemodilution in peripheral arterial disease.
Rieger H; Köhler M; Schoop W; Schmid-Schönbein H
Ann Clin Res; 1981; 13 Suppl 33():78-83. PubMed ID: 7342848
[TBL] [Abstract][Full Text] [Related]
3. [Kinetic effects of 6% hydroxyethyl starch 200.000/0.6-0.66 in hypervolemic hemodilution].
Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
Acta Med Austriaca; 1991; 18 Suppl 1():20-2. PubMed ID: 1719728
[TBL] [Abstract][Full Text] [Related]
4. Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment.
Toth K; Kesmarky G; Vekasi J; Nemes J; Czopf L; Kapronczay P; Halmosi R; Papp E; Juricskay I
Clin Hemorheol Microcirc; 1999; 21(3-4):209-16. PubMed ID: 10711745
[TBL] [Abstract][Full Text] [Related]
5. [Hemodynamics in controlled normovolemic hemodilution in patients with obliterative vascular diseases].
Kuznetsov NA
Vestn Khir Im I I Grek; 1986 Feb; 136(2):126-31. PubMed ID: 3518191
[TBL] [Abstract][Full Text] [Related]
6. [Hypervolemic hemodilution with medium molecular-weight hydroxyethyl starch: effect of duration of administration on viscoelasticity of blood in IIa and IIb peripheral arterial occlusive disease].
Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
Acta Med Austriaca; 1991; 18 Suppl 1():45-7. PubMed ID: 1719731
[TBL] [Abstract][Full Text] [Related]
7. [Hemodilution in peripheral arterial occlusive disease--study comparing 3 different variants of hemodilution].
Weidinger P; Bilek M; Tekusch A
Vasa Suppl; 1990; 30():137-8. PubMed ID: 2075564
[No Abstract] [Full Text] [Related]
8. [The influence of hemorrheology on the practice of clinical medicine].
Dormandy JA
Ric Clin Lab; 1983; 13 Suppl 3():7-27. PubMed ID: 6369497
[TBL] [Abstract][Full Text] [Related]
9. [Hemodilution in patients with multiple morbidity and peripheral arterial occlusive disease].
Kiesewetter H; Blume J; Jung F; Spitzer S; Bach R; Birk A; Schieffer H; Wenzel E
Schweiz Med Wochenschr; 1989 Dec; 119(51):1862-7. PubMed ID: 2481883
[TBL] [Abstract][Full Text] [Related]
10. Isovolemic hemodilution as a functional therapy of decompensated arteriosclerotic stenoses of the femoral, cerebral and ophthalmic artery.
Schmid-Schönbein H; Rieger H
Ric Clin Lab; 1983; 13 Suppl 3():29-52. PubMed ID: 6673004
[TBL] [Abstract][Full Text] [Related]
11. [Hemorrheological factors in the developmental stages of peripheral arterial occlusive diseases].
Artale F; Sergio G; Cramarossa L; Giunti P; Francisci A; Perego MA
Ric Clin Lab; 1983; 13 Suppl 3():411-5. PubMed ID: 6673022
[TBL] [Abstract][Full Text] [Related]
12. [Rheologic effects of normovolemic hemodilution].
Kuznetsov NA; Aleksandrova NP; Bogdanov AE; Rogulenko RV
Anesteziol Reanimatol; 1990; (2):18-22. PubMed ID: 1698041
[TBL] [Abstract][Full Text] [Related]
13. [Dynamics of regional blood circulation in normovolemic hemodilution in patients with arterial occlusive diseases].
Kuznetsov NA; Bogdanov AE
Vestn Khir Im I I Grek; 1987 Sep; 139(9):19-24. PubMed ID: 3441964
[TBL] [Abstract][Full Text] [Related]
14. [Rheological effects of normovolemic hemodilution].
Cozette P; Gaillard S; Rose E; Carnielo M
Ann Anesthesiol Fr; 1979; 20(9):775-83. PubMed ID: 45288
[TBL] [Abstract][Full Text] [Related]
15. [Multi-distributed ischemia and degree of hemorrheological changes].
Sergio G; Artale F; Francisci A; Perego MA
Ric Clin Lab; 1983; 13 Suppl 3():427-30. PubMed ID: 6673025
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of peripheral arterial occlusive disorders with rheologically active measures].
Turowski A; Schmidt HH; Sternitzky R
Z Arztl Fortbild (Jena); 1987; 81(17):883-8. PubMed ID: 3439205
[No Abstract] [Full Text] [Related]
17. [Diluted albumin-dextran 40 combination in treating arteriopathy of the lower extremities by normovolemic hemodilution. The rheological effects].
Stoltz JF; Chevraud C; Voisin P; Burdin D; Streiff F; Laxenaire MC
J Mal Vasc; 1986; 11(4):344-50. PubMed ID: 2433377
[TBL] [Abstract][Full Text] [Related]
18. [Induced hemodilution as a new concept in the therapy of peripheral circulatory disorders].
Rieger H
Internist (Berl); 1982 Jul; 23(7):375-82. PubMed ID: 7049999
[No Abstract] [Full Text] [Related]
19. Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV study.
Koscielny J; Latza R; Pruss A; Kiesewetter H; Jung F; Meier C; Schimetta W
Clin Hemorheol Microcirc; 2000; 22(1):53-65. PubMed ID: 10711822
[TBL] [Abstract][Full Text] [Related]
20. [Hemorrheological survey in a group with arteriosclerotic vascular disease treated with suloctidil].
Caimi G; Catania A; Frazzetta F; Capobianco D; Francavilla G; Romano A; Sarno A
Ric Clin Lab; 1983; 13 Suppl 3():465-8. PubMed ID: 6324326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
